Wyszukiwarka
Filtry
wszystkich: 4
Wyniki wyszukiwania dla: PTX
-
Advanced oxidation treatment of Pentoxifylline in aqueous solution
PublikacjaThe degradation of pentoxifylline (PTX) using H2O2, UV, H2O2/UV, Fenton and photo- Fenton processes has been examined in aqueous solution. The influence of various amount of oxidation agent on H2O2, H2O2/UV, Fenton and photo-Fenton reactions were investigated. Initial PTX concentration in Fenton and photo-Fenton was considerated. The addition of inorganic ions (Cl-, NO3-, SO42- and CO32-) on the degradation efficiency of PTX were...
-
Preliminary in vivo studies of a new lecitin-based formulation of paclitaxel
PublikacjaPrzeprowadzono wstępne badania in vivo of PTX opartego na lecytynie. Roztwór jest stabilny przez 24 godziny. Po podaniu królikom dawki 0,66mg/kg/h nie zanotowano zmian morfologicznych krwi w porównaniu do komercyjnego produktu Taxol.
-
Degradation kinetics and mechanism of pentoxifylline by ultraviolet activated peroxydisulfate
PublikacjaDegradation of pentoxifylline (PTX) by sodium peroxydisulfate (SPDS) assisted by UV irradiation has been investigated in deionized water. The treatment was more favorable over direct photolysis or peroxydisulfate oxidation alone. The effects of various parameters, including different dosage of oxidant agent, PTX concentration, initial solution pH levels, and the presence of inorganic ions like chloride, nitrate and carbonate have...
-
Combined anticancer therapy with imidazoacridinone analogue C‐1305 and paclitaxel in human lung and colon cancer xenografts—Modulation of tumour angiogenesis
PublikacjaThe acridanone derivative 5-dimethylaminopropylamino- 8- hydroxytriazoloacridinone (C-1305) has been described as a potent inhibitor of cancer cell growth. Its mechanism of action in in vitro conditions was attributed, among others, to its ability to bind and stabilize the microtubule network and subsequently exhibit its tumour- suppressive effects in synergy with paclitaxel (PTX). Therefore, the objective of the present study...